| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0092 | 1 |